Search - tctmd.com

Displaying 81 - 100 of 1211

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Philips Recalls Tack Endovascular Systems and Stops Distribution

L.A. McKeown

March 03, 2025

Presentation CTO 2025

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Presenter: Omar Abdelhai

February 28, 2025

Presentation CTO 2025

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Presenter: Brian Li

February 28, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

L.A. McKeown

February 07, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Ikuta Akihiro

October 29, 2024

Presentation TCT 2024

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Dealla Samadi

October 29, 2024

Presentation TCT 2024

TCT 1103: Simple Solution for Stent Restenosis Due to Non-Expandable Calcified Lesions: A Clinical Case

Presenter: QUAN NGUYEN MANH

October 29, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Presenter: Jiasheng Yin

October 29, 2024

Advertisement

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Philips Recalls Tack Endovascular Systems and Stops Distribution

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

Top Endovascular News of 2024

Top Coronary Artery Disease News in 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 1103: Simple Solution for Stent Restenosis Due to Non-Expandable Calcified Lesions: A Clinical Case

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content